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Partial Rescue of the p35/ Brain Phenotype by Low
Expression of a Neuronal-Specific Enolase p25 Transgene
Holger Patzke,1,2 Upendra Maddineni,1,2 Ramses Ayala,1 Maria Morabito,1 Janet Volker,1 Pieter Dikkes,3
Michael K. Ahlijanian,4 and Li-Huei Tsai1,2
1Department of Pathology and 2Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02115, 3Department of Neurology,
Children’s Hospital, Boston, Massachusetts 02115, and 4Department of CNS Discovery, Pfizer Central Research, Groton, Connecticut 06340
Cyclin-dependent kinase 5 (Cdk5) is activated on binding of activator proteins p35 and p39. A N-terminally truncated p35, termed p25, is
generated through cleavage by the Ca 2-dependent protease calpain after induction of ischemia in rat brain. p25 has been shown to
accumulate in brains of patients with Alzheimer’s disease and may contribute to A-peptide-mediated toxicity. Studies from transfected
neurons as well as p35 and p25 transgenic mice have indicated that Cdk5, when activated by p25, gains some toxic function compared with
p35/Cdk5. It remains unclear, however, whether p25/Cdk5 signaling additionally channels into pathways usually used by p35/Cdk5 and
whether p25 is associated with a loss of p35 function. To clarify these issues, we have generated p25-transgenic mice in a p35-null
background. We find that low levels of p25 during development induce a partial rescue of the p35/phenotype in several brain regions
analyzed, including a rescue of cell positioning of a subset of neurons in the neocortex. In accordance with the partial rescue of brain
anatomy, phosphorylation of the Cdk5 substrate mouse disabled 1 is partially restored during development. Besides this, p25/Cdk5 fails
to phosphorylate other substrates that are normally phosphorylated by p35/Cdk5. Our results show that p25 can substitute for p35/Cdk5
under certain circumstances during development. In addition, they suggest that p25 may have lost some functions of p35.
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Introduction
Cyclin-dependent kinase 5 (Cdk5) is a Ser-Thr kinase that is
activated on binding to p35 or p39, two closely related proteins
predominantly expressed in neurons (Dhavan and Tsai, 2001).
Cdk5/ and p35/p39 double knock-out mice die perinatally
and display severe neuronal lamination defects in several brain
areas suggestive of impaired neuronal migration (Ohshima et al.,
1996, 1999; Gilmore et al., 1998; Gilmore and Herrup, 2001; Ko et
al., 2001). The phenotype of p35/mice is less pronounced but
similar to the one of Cdk5/mice, but the mice are viable and
fertile (Chae et al., 1997; Kwon and Tsai, 1998).
Recently, it has been shown that p35 is cleaved by the Ca 2-
dependent Cys protease calpain after induction of ischemia in the
brain (Lee et al., 2000; Nath et al., 2000). Calpain cleaves p35 in
the N-terminal domain, which results in the generation of a
C-terminal truncation product termed p25. p25 contains all ele-
ments necessary for Cdk5 catalytic activation and activates Cdk5
in vitro and in vivo (Lew et al., 1994; Ahlijanian et al., 2000; Bian
et al., 2002). In addition to ischemia, generation of p25 in the
nervous system has been described in patients with Alzheimer’s
disease, in a mouse model of familial amyotrophic lateral sclero-
sis, and in a mouse model of Niemann–Pick type C disease
(Patrick et al., 1999; Nguyen et al., 2001; Bu et al., 2002; Tseng et
al., 2002). Furthermore, neurons challenged with toxic A- pep-
tide display increased p25 generation, and inhibition of Cdk5 or
calpain partially prevents neuronal cell death in this system (Al-
varez et al., 1999; Lee et al., 2000). In sum, these data suggest that
p25/Cdk5 contributes to neuronal cell death after neurotoxic
insults.
Transgenic mice that overexpress p25 (p25-tg) under the
neuronal-specific enolase (NSE) promoter show disruption of
the axonal cytoskeleton and hyperphosphorylation of the
microtubule-associated protein tau and of neurofilament sub-
units (Ahlijanian et al., 2000). Mice transgenic for p35 do not
exhibit a comparable phenotype, arguing that signaling by the
p25/Cdk5 complex differs from signaling by p35/Cdk5 (Van den
Haute et al., 2001). Indeed, expression of p25/Cdk5 in COS-7
cells leads to hyperphosphorylation of tau, whereas similar levels
of p35/Cdk5 fail to do so, suggesting a toxic gain of function by
p25/Cdk5 (Patrick et al., 1999). This is further supported by in
vitro studies demonstrating that p25/Cdk5 is more effective at
phosphorylating tau than p35/Cdk5, and that it might target sites
within tau that are only poorly phosphorylated by p35/Cdk5
(Hashiguchi et al., 2002). Although these studies investigated a
possible toxic gain of function of p25/Cdk5, they did not address
the question of whether further differences might exist between
p25/Cdk5 and p35/Cdk5 signaling. In particular, it remains un-
clear whether p25/Cdk5 can signal in pathways normally used by
p35/Cdk5 and whether p25/Cdk5 has lost some functions of p35/
Cdk5 signaling.
To address this question, we have generated NSE p25-tg mice
in a p35/ background. This allowed us to compare p25/Cdk5
with p35/Cdk5 signaling in vivo by analysis of the developmental
p35/ phenotype and the phosphorylation of endogenous
substrates of Cdk5. On the basis of our results, we suggest that
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p25/Cdk5 can signal through pathways used by p35/Cdk5 but
also may have lost some p35/Cdk5 function.
Materials and Methods
Generation of p25-tg/p35/ mice. Generation of mice expressing p25
under the control of the NSE promoter and of p35/ mice has been
described previously (Chae et al., 1997; Ahlijanian et al., 2000). To pro-
duce p25-tg/p35/ mice, hemizygous p25-tg mice were mated with
p35/mice. F1 p25-tg/p35/mice were mated again with p35/
mice to obtain the desired F2 p25-tg/p35/ offspring as well as
p35/, p35/, and p25-tg/p35/ control mice. Additional con-
trols were generated by crossing p25-tg mice with p35/mice over two
generations to produce F2 p35/ and p25-tg/p35/ animals. For
analysis, littermates were used whenever possible. Genotypes were deter-
mined by PCR on genomic tail DNA, as published previously (Kwon and
Tsai, 1998; Ahlijanian et al., 2000).
Histochemical and immunohistochemical analysis. Adult mice (6
months–2 years old) were anesthetized by intraperitoneal injections of
Avertin (10 ml/kg body weight; Aldrich, Milwaukee, WI). Anesthetized
animals were transcardially perfused with 0.1 M sodium phosphate
buffer, pH 7.4, to remove blood. Next, animals were fixed by perfusion
with 70 ml of 4% paraformaldehyde in 0.1 M sodium phosphate buffer,
pH 7.4, or Bouin’s fixative (Polysciences, Warrington, PA). Dissected
brains were fixed at 4°C either for 20 –24 hr in 4% paraformaldehyde
solution or for 48 hr in Bouin’s fixative. To perform histology, brains
were embedded in paraffin, cut into 6- to 7-m-thick sections, and
stained with hematoxylin and eosin or cresyl violet using standard pro-
cedures. Three or more animals of each genotype were analyzed. To label
fibers within the brain, we used a reduced silver fiber-staining technique
according to previously published procedures (Desclin and Escubi,
1975).
Immunohistochemical staining was performed on paraformaldehyde-
fixed sections using the avidin– biotin–peroxidase complex technique
(Vector Laboratories, Burlingame, CA) with diaminobenzidine as a sub-
strate. Calbindin D-28-K (Sigma, St. Louis, MO; 1:3000) and SMI 32 and
SMI 34 (Sternberger Monoclonals Inc., Lutherville, MD; both 1:1000)
antibodies were used for staining according to the instructions of
the manufacturers. SMI 32 reacts with a nonphosphorylated epitope
in the neurofilament H chain. SMI 34 detects a phosphorylated
epitope in neurofilament H and to a lesser extent in the neurofilament
M chain.
Western blot analysis. Timed pregnant mice were killed, and embryos
were collected in ice-cold HBSS and 20 mM HEPES, pH 7.3. The cerebral
cortex anlage or the cerebral cortex of adult animals was dissected and
lysed in radioimmune precipitation assay buffer [50 mM Tris, 150 mM
NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 pro-
tease inhibitor mixture (Roche Molecular Biochemicals, Mannheim,
Germany), and phosphatase inhibitors 1 mM sodium fluoride, 1 mM sodium
orthovanadate, 2 mM imidazole, and 25 mM -glycerophosphate]. Lysates
were homogenized and spun at 16,000 g for 5 min. Supernatants were
removed, mixed 1:1 with 2 sample buffer, boiled for 5 min, quick-
frozen, and stored at – 80°C.
Samples were analyzed by SDS-PAGE in 8% polyacrylamide gels for
postsynaptic density 95 (PSD-95) protein, in 10% gels for mouse dis-
abled 1 (mDab1), NUDE-like (NUDEL), and tau proteins, and in 12%
gels for p25, p35, and p39 proteins. Proteins were transferred to an
Immobilon-P transfer membrane (Millipore, Bedford, MA). Blots were
subjected to protein detection by incubation with various antibodies
diluted in Tris-buffered saline (in mM: 25 Tris, 137 NaCl, and 2.7 KCl, pH
7.4) containing 0.2% Tween 20 and 5% nonfat dry milk. Bound antibod-
ies were visualized using enhanced chemiluminescence solutions
(PerkinElmer Life Sciences, Boston, MA). Affinity-purified rabbit poly-
clonal antibodies to p35 and p39 have been described previously (Tsai et
al., 1994; Humbert et al., 2000) and were used at 1 g/ml. Mouse mono-
clonal antibody (clone AC-40) to actin was purchased from Sigma and
used at a 1:2000 dilution. Mouse monoclonal antibody to mDab1 was a
kind gift from Dr. A. M. Goffinet (University Louvain Medical School,
Brussels, Belgium) and was used at a 1:250 dilution. Phospho-epitope-
specific antibody to mDab1 phosphorylated at Ser-491 was generated by
injection of a keyhole limpet hemocyanin (KLH)-coupled peptide with
the sequence PAPRQS(phosphoS)PSKSSC into rabbits (Keshvara et al.,
2002). Rabbit serum was affinity-purified by a phospho-peptide column
and proven to specifically recognize mDab1 phosphorylated at Ser-491
and was used at a dilution of 1:1000. Rabbit antibody to NUDEL (serum
211) was described previously and was used at 0.2g/ml (Niethammer et
al., 2000). Phospho-epitope-specific antibody to Ser-231 of NUDEL was
made by injection of the KLH-coupled peptide TENTFP(phosphoS)P-
KAIPC into rabbits. Rabbit serum was first affinity-purified by a column
containing resin-bound peptide, which was not phosphorylated at Ser-
231. The flow-through was further purified by a phospho-peptide col-
umn and proven to specifically recognize NUDEL phosphorylated at
Ser-231 and was used at a dilution of 1:500. Mouse monoclonal antibody
to PSD-95 (clone K28/43) was obtained from Upstate Biotechnology
(Lake Placid, NY) and used at a 1:10,000 dilution. Affinity-purified rabbit
antibody specific to PSD-95 phosphorylated at Thr-19 and Ser-25 was
generated by injection of a KLH-coupled peptide with the sequence QD-
ED(phosphoT)PPLEH(phosphoS)PAHC into rabbits. Rabbit serum was
first affinity-purified by a column containing resin-bound peptide,
which was not phosphorylated at Thr-19 and Ser-25. The flow-through
was further purified by a phospho-peptide column and proven to specif-
ically recognize PSD-95 phosphorylated at Thr-19 and Ser-25. The anti-
body was used at a 1:50 dilution. Mouse monoclonal antibody recogniz-
ing total tau (clone TAU-5, reacts with phosporylated and
nonphosphorylated forms) was purchased from Neomarkers and was
used at a 1:250 dilution. Rabbit polyclonal antibody against phosphory-
lated Ser-202 of tau was obtained from Biosource (Camarillo, CA) and
was used at a 1:1000 dilution. Mouse monoclonal antibody PHF-1 was a
kind gift from Dr. P. Davies (Albert Einstein College of Medicine, New
York, NY) and was used at a 1:100 dilution. PHF-1 detects tau phospory-
lated at Ser-396 and Ser-404.
Densitometric analysis. Quantitation of optical density of Western blot
signals was performed on scanned films by NIH Image 1.62 analysis
software. Values for phospho-epitope-specific signals were divided by
values for total protein signals. To allow for comparison between differ-
ent litters, ratios obtained from p35/ or p25-tg/p35/ animals
were normalized to the average ratio derived from p35/ control an-
imals (which was arbitrarily set to 1) within a single litter. Normalized
ratios from p35/ and p25-tg/p35/ mice were then used to per-
form statistical analysis (n  3–5 for each genotype and each develop-
mental stage; unpaired, two-tailed t test).
Results
Partial restoration of cytoarchitecture in the cerebral cortex
of p25-tg/p35/mice
The mature cerebral cortex is characterized by organization of
neurons into readily distinguishable layers. During development,
neurons born in the ventricular zone migrate radially toward the
pial surface to settle in their final position within the cerebral
wall. To establish this pattern, later-born neurons migrate past
their predecessors, resulting in a so-called “inside-out” layer for-
mation (Bayer and Altman, 1991).
To assess whether p25 can substitute for p35 in vivo, we
crossed p25-tg mice with p35/ mice. We then compared the
morphology of the cerebral cortex among wild-type (wt),
p35/, p25-tg, and p25-tg/p35/ mice after cresyl violet
staining (Fig. 1A). The wt cerebral cortex shows morphological
organization into six layers, including the large pyramidal neu-
rons of layer V. In contrast, p35/ mice display an apparent
loss of the laminar structure within the cerebral cortex, with most
large pyramidal neurons normally found in layer V located just
beneath layer I. This phenotype has been explained by the inabil-
ity of later-born neurons to migrate past earlier-born ones, re-
sulting in an inverted layering order within the cerebral cortex
(Chae et al., 1997; Kwon and Tsai, 1998; Kwon et al., 2000). In
p25-tg/p35/mice, most large pyramidal neurons are located
in a position close to the one found in the wt cortex. The neurons
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are located superficial to their normal position, corresponding
approximately to the location where layer IV neurons normally
reside. In addition, the superficial aspect of the cerebral cortex
acquires some laminar structure, although it remains less orga-
nized than in wt mice. Control p25-tg mice exhibit the same
cortical organization as wt mice (Fig. 1A) and display normal
gross brain morphology (Ahlijanian et al., 2000). In summary,
expression of the p25-tg in a p35-null background results in a
partial rescue of the developmental p35/ lamination pheno-
type in the cerebral cortex.
Restoration of morphology in the
hippocampus and the cerebellum of
p25-tg/p35/mice
In addition to the cerebral cortex, other
brain regions whose laminar organization
is affected in p35/ mice include the
hippocampus and the cerebellum (Chae
et al., 1997; Ohshima et al., 2001). The
hippocampus of p35/ mice is charac-
terized by loose packing and occasional
interruption of CA1 and CA3 neuronal
layers as well as the granule cell layer of the
dentate gyrus (Fig. 1B). In contrast, p25-
tg/p35/ mice display a hippocampal
formation, which seems almost indistin-
guishable from that of the wt hippocam-
pus. The only abnormality we noticed was
a slight decrease in the density of neurons
at the border between CA1 and CA3 lay-
ers. The hippocampus of control p25-tg
mice is indistinguishable from that of wt
mice (data not shown).
The main feature of the cerebellum of
p35/ mice is a molecular layer that is
filled with cells resembling granular cells
(Fig. 1C). Expression of the p25 transgene
in p35-null mice leads to a pronounced
reduction of ectopic cells in the molecular
layer, although their density still seems
slightly increased in comparison with the
wt cerebellum. The cerebellum of control
p25-tg mice appears normal (data not
shown). Taken together, expression of
p25 in the p35/ mice results in allevi-
ation of the developmental lamination de-
fects in the hippocampus and the cerebel-
lum. This provides evidence that p25/
Cdk5 can substitute to a significant extent
for p35/Cdk-mediated signaling in these
brain structures.
Analysis of p25-tg/p35/mice
cortices by neuronal
subtype-specific markers
As indicated by histochemical staining
(Fig. 1A), the laminar configuration of the
cerebral cortex becomes partially restored
in p25-tg/p35/ mice compared with
p35-null mice. To investigate this in more
detail and not solely based on morpholog-
ical criteria, we performed immunohisto-
chemistry with antibodies against calbi-
ndin and neurofilament chains to identify
neuronal subpopulations. Calbindin staining identifies lightly la-
beled pyramidal neurons of layers II and III as well as a darkly
marked fraction of GABAergic interneurons scattered throughout
the adult cerebral cortex (Fig. 2A,A,A) (Hendry et al., 1989; Van
Brederode et al., 1990; Stuhmer et al., 2002). In p35/mice, su-
perficial layers are devoid of lightly stained pyramidal neurons in
dorsomedial parts of the cortex (Fig. 2B). Instead, layer II and III
late-born neurons remain in deep layers of the cortex, in accordance
with the inverted layering phenotype described in p35/ mice.
Abnormal layering in p35-null mice is more pronounced in dorso-
Figure 1. Partial rescue of cytoarchitecture in the brain of p25-tg/p35/ mice. A, Cerebral cortex. Coronal sections of
paraformaldehyde-fixed and paraffin-embedded brains from 6-month-old mice were stained with cresyl violet. Images are taken
from the motor cortex area at the level of the anterior commissure. Genotypes are as indicated. The wt cortex displays distinct
neuronal cell layers marked I–VI. Large pyramidal neurons are located in layer V, whose center is marked by an asterisk. In the
p35/ cortex, large pyramidal neurons are located in ectopic superficial positions (asterisk). Cell layering is severely disturbed.
The cortex of p25-tg mice appears normal. In p25-tg/p35/mice, large pyramidal neurons are located in a layer (asterisk) that
resides in a slightly superficial position compared with wild-type animals. The superficial aspect of the cortex displays some
restoration of layer formation. Note the loss of corpus callosum (cc) fiber tract in p35/ cortex. The corpus callosum is restored
in p25-tg/p35/mice but appears disorganized. Medial is to the left; dorsal is at the top. B, C, Restoration of morphology in the
hippocampus ( B) and the cerebellum ( C ) of p25-tg/p35/ mice. Coronal sections of Bouin’s-fixed and paraffin-embedded
brains from 9-month-old mice were stained with hematoxylin and eosin. B, The wt hippocampus displays the normal configuration
of densely packed CA1, CA3, and dentate gyrus (DG) cell layers. The hippocampus of p35/ mice shows loose packing and
occasional disruptions of neuronal cell layers (arrowheads) and is oddly shaped. In p25-tg/p35/mice, neuronal layering and
overall shape of the hippocampus appear to be largely normal. Medial is to the left; dorsal is at the top. C, The cerebellum of
wild-type mice displays characteristic laminar organization into a cell-sparse molecular layer (ML), a Purkinje cell layer ( P), and a
granule cell layer (GCL). The molecular layer in the p35/ cerebellum shows an increased density of cells with a granule cell-like
morphology. In p25-tg/p35/mice, the cell density in the molecular layer is strongly reduced compared with p35/mice
but seems still slightly elevated when compared with wild-type mice. Medial is at the top; dorsal is to the left. Scale bars, 200m.
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medial parts compared with ventrolateral
parts of the cortex (Chae et al., 1997). In-
deed, the abnormal distribution of
calbindin-expressing neurons is more obvi-
ous in dorsomedial versus ventrolateral
parts of the cortex (Fig. 2B). Notably, in
p25-tg/p35/ mice, calbindin-positive
neurons resume their normal position ven-
tral to layer I (Fig. 2C). This finding suggests
that p25/Cdk5 can signal in the same man-
ner as p35/Cdk5 normally signals regarding
cell positioning during development. In the
cingulate cortex and medial motorcortex,
the rescue seems almost complete, whereas
more laterally calbindin-positive neurons
are still found in ectopic positions in deep
cortical layers, although they are less abun-
dant compared with p35/mice.
Interestingly, darkly stained neurons
with nonpyramidal morphology remain
scattered throughout the cortex in p35/
mice (Fig. 2B,B,B), suggesting that their
positioning within the cortex is unaffected
by loss of p35. A similar result in the posi-
tioning of calbindin-positive and GABAer-
gic neurons was observed in Cdk5/7
wild-type chimeric mice (Gilmore and Her-
rup, 2001). Therefore, our observation sup-
ports the conclusion that positioning of
GABAergic interneurons is unaffected in
mice with compromised Cdk5 activity (Gil-
more and Herrup, 2001).
Antibodies to neurofilament heavy
chain (SMI 32) label large pyramidal neu-
rons in layers III and V in the adult mam-
malian cortex (Campbell and Morrison,
1989; Graus-Porta et al., 2001). In the mo-
torcortex area, the staining identifies
mostly large pyramidal neurons of layer V
in the wild-type mouse brain (Fig. 2D). In
the p35/ cortex, staining is detected in
large neurons that are scattered through-
out an area normally occupied by layer II
and III neurons (Fig. 2E). In contrast,
p25-tg/p35/ mice display a discrete
layer of SMI 32-positive neurons (Fig.
2F). The position of this layer is signifi-
cantly rescued in that the neurons are
slightly superficial to what would be ex-
pected in the wild-type brain. Opposite to p35/ mice, very
few SMI 32-positive neurons are found in locations just ventral to
layer I. These results confirm the observations made after histo-
chemical staining of the cortex (Fig. 1A). In summary, p25/Cdk5
expression is sufficient for a subset of calbindin-positive neurons
to reach their normal position within the cortex of the compound
mice. Moreover, positioning of SMI 32-positive neurons appears
rescued to some extent in p25-tg/p35/mice (see Discussion).
Partial rescue of the p35/ corpus callosum phenotype in
the compound mice
In addition to lamination abnormalities, p35/mice display a
prominent disruption of corpus callosum morphology (Chae et
al., 1997; Kwon et al., 1999). In contrast, Reeler mice, which show
an inverted layering phenotype, have normal corpus callosum
morphology (Caviness, 1976; Terashima et al., 1985; Aoki et al.,
2001). This suggests that the aberrant corpus callosum morphol-
ogy observed in p35-null mice is a primary defect and not sec-
ondary because of malpositioning of neurons (Kwon et al., 1999).
Using a modified silver-staining technique to visualize neuronal
projections, we investigated whether expression of p25 affects the
formation of fiber tracts in p35-null mice. In p35/ mice,
fibers defasciculate from the corpus callosum adjacent to the
midline, resulting in a markedly reduced thickness of the corpus
callosum when compared with wt mice (Fig. 3A,B). Furthermore,
aberrant fiber fascicles course through the neocortex. In p25-tg/
p35/ mice, the corpus callosum morphology is restored ad-
jacent to the midline (Fig. 3C,D). Moving laterally, it is apparent
Figure 2. Analysis of p25-tg/p35/ cortices by neuronal subtype-specific markers. Coronal sections of paraformaldehyde-
fixed brains were stained with anti-calbindin antibody ( A–C ) or anti-neurofilament antibody SMI 32 ( D–F ). Genotypes are as
indicated. A–C, Superficial layers of the medial motorcortex. A–C, Corresponding deep layers of the medial motorcortex. C,
Deep layers of lateral the motorcortex. A, In the cerebral cortex of 9-month-old wt mice, calbindin staining labels mostly layer II and
III neurons. A, Magnification of the wt superficial motor cortex area reveals lightly stained pyramidal neurons (arrow) as well as
darkly stained presumptive inhibitory neurons (arrowhead). A, Magnification of corresponding deep cortical layers shows few
darkly labeled nonpyramidal inhibitory neurons. B, In p35/ mice, calbindin-positive neurons fail to populate their normal
position but localize to deep cortical areas (asterisks). More laterally, however, calbindin-positive neurons can be found in normal
positions (lateral of arrow). B, Magnification of an area comparable with A displays few darkly stained neurons but no pyramidal
neurons usually found in this location. Instead, they are found in deep cortical layers (B) along with some inhibitory neurons. C, In
p25-tg/p35/mice, the distribution of calbindin-positive neurons is partially restored. Notably, the localization of calbindin-
positive neurons in the cingulate cortex and in the medial motorcortex (arrowheads) appears primarily normal (compare A, C ).
More laterally, the superficial layer of calbindin-positive neurons seems thinned compared with wild-type animals, and the
staining reveals neurons remaining in deep cortical positions (asterisk). C, Enlargement of superficial layers in the medial motor-
cortex demonstrates calbindin-positive pyramidal neurons (arrow) in their normal position but not in deep cortical layers (C ),
which display only a few inhibitory neurons (arrowhead). C, Unlike deep layers in the medial motorcortex (C ), corresponding
layers in the lateral motorcortex still contain lightly stained pyramidal neurons (arrow). D, Staining of wild-type brains with SMI 32
labels mostly large pyramidal neurons in layer V of the motorcortex. E, In p35/mice, the staining identifies large pyramidal
neurons scattered abnormally in superficial layers of the motorcortex. Note aberrant fiber fascicles coursing through the cortex. F,
In p25-tg/p35/ mice, the staining labels a discrete layer of large pyramidal neurons. Unlike in p35/ mice, areas just
ventral to layer I are mostly devoid of ectopic SMI 32-positive neurons. The stained layer is somewhat superficially positioned
compared with wild-type mice. For all images, medial is to the left; dorsal is at the top. Scale bars, 200m.
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that the corpus callosum is still thinned and less compact,
although the defect is reduced compared with p35-null mice.
Moreover, no aberrant fiber fascicles are found in superficial lay-
ers of the neocortex, indicative of a restoration of normal cell
layering in the cortex (Caviness, 1976; Caviness and Yorke, 1976).
These results show that the organization of fiber tracts associated
with the neocortex can be partially rescued by p25/Cdk5 signaling
in p35/ mice, indicating that p25 can substitute for p35 in
developmental contexts other than cell-positioning defects.
Increased levels of p39 do not account for the rescue observed
in p25-tg/p35/mice
The phenotypic rescue of our compound mice suggested that
Cdk5 signaling was partially restored during brain development.
p39, the other major activator of Cdk5 in the brain, is upregulated
in p35/ mice, indicating that levels of p39 are regulated by
p35 (Ko et al., 2001). To exclude the possibility that the pheno-
typic rescue we observed is simply a result of increased p39 levels,
we investigated whether p39 levels are altered by expression of the
p25 transgene during development. As control mice, we used
p35/ mice, which are phenotypically normal (Chae et al.,
1997). Throughout development, levels of p39 in the cerebral
cortex are increased in p35/ mice in comparison with p35
heterozygous mice, in accordance with previously described re-
sults (Fig. 4A–D) (Ko et al., 2001). The levels of p39 in p25-tg/
p35/mice are very similar to those in p35-null animals (Fig.
4A–D). Therefore, expression of p25 did not alter p39 levels. In
summary, our results suggest that the phenotypic rescue in the
compound mice is a direct consequence of p25/Cdk5 signaling
rather than an indirect effect attributable to increased p39/Cdk5
signaling.
Reduced expression of the p25
transgene compared with endogenous
p35 during development
The partial rescue of the p35/ pheno-
type in the compound mice indicates in-
creased p25/Cdk5 signaling during brain
development. Given the incompleteness
of the rescue, however, we were interested
in exploring whether differences might
exist between the levels of p25 expressed
from the transgene and endogenous p35
during development of the cerebral cor-
tex. To allow for direct comparison of p25
and p35 levels in the same animals, we
performed a detailed Western blot analy-
sis in p25-tg/p35/ mice throughout
embryonic development. Levels of p35
and p25 are low during early [embryonic
day 10.5 (E10.5)] cortex development
compared with levels of the cytoskeletal
protein actin (Fig. 4E). The identity of
weak p25 and p35 bands was confirmed in
control animals lacking either p25 (data
not shown) or p35 (Fig. 4E). p35 levels
increase substantially between E10.5 and
E12.5, whereas p25 levels remain low.
During further development, p35 levels
increase slowly until postnatal day 0 (P0),
the last age analyzed. Notably, although
p25 levels steadily increase until P0, they
remain reduced compared with p35 over
the entire time frame covered. Determi-
nation of p25 levels at E12.5, E16, and P0 in the compound mice
reveals results similar to those in p25-tg/p35/ animals. Taken
together, transgenic p25 levels are reduced compared with en-
dogenous p35 levels during embryonic development of the cere-
bral cortex.
Phosphorylation of endogenous Cdk5 substrates
during development
To explore differences in p25/Cdk5 to p35/Cdk5 signaling in vivo,
we analyzed the phosphorylation of known endogenous sub-
strates of Cdk5 during development. The partial rescue of the
p35/ phenotype in p25-tg/p35/ mice suggested that
physiological substrates of p35/Cdk5 were phosphorylated by
p25/Cdk5 during development. Therefore, we chose to analyze
the phosphorylation of mDab1 at Ser-491, a residue that shows
diminished phosphorylation in the Cdk5/ brain at E16.5 and
P0 (Keshvara et al., 2002). Western blot analysis conducted with
an antibody that specifically detects mDab1 phosphorylated at
Ser-491 reveals decreased phosphorylation in the E16 cortex of
p35/mice compared with p35/ control animals (Fig. 5A).
Densitometric quantification of signals for Ser-491 phosphoryla-
tion (relative to total mDab1) demonstrates a decrease by60%
in p35-null mice compared with p35/ animals, which is con-
sistent with results obtained in Cdk5/ animals (Keshvara et
al., 2002). In p25-tg/p35/ animals, Ser-491 phosphorylation
is significantly increased over that in p35/ animals at E16;
however, it is still decreased compared with p35/ control
animals. In P0 animals, phosphorylation of Ser-491 remains re-
duced by60% in p35/mice compared with p35/mice.
Again, phosphorylation of Ser-491 is significantly increased in
the compound mice compared with p35/ animals. Addition-
Figure 3. Partial rescue of p35/ corpus callosum phenotype in p25-tg/p35/ mice. Coronal sections of
paraformaldehyde-fixed brains from 6-month-old mice were stained with a reduced silver technique to reveal fiber tracts. A, In the
wt brain, the corpus callosum is tightly fasciculated. B, p35/mice display a reduced corpus callosum except for the part close
to the midline (medial of arrowhead). In addition, thick aberrant fiber fascicles course through the cortex, which are not seen in
wild-type mice. C, D, In p25-tg/p35/mice, corpus callosum morphology is significantly restored (compare areas just lateral to
arrowheads in B–D). However, the corpus callosum remains loosely organized in more lateral aspects of the brain (arrows). Unlike
in the p35/ cortex, aberrant fiber fascicles are not prominent in superficial layers. C, Anterior part of the corpus callosum; D,
more posterior part of the corpus callosum. Medial is to the left; dorsal is at the top. Scale bar, 200m.
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ally, levels of phosphorylation at P0 are
higher compared with E16, and this might
reflect increased expression of p25 at later
stages (Fig. 4E). Taken together, these re-
sults show that expression of p25 can par-
tially restore phosphorylation of an en-
dogenous substrate of p35/Cdk5 during
cortex development.
Another endogenous substrate of Cdk5 is
PSD-95. Phosphorylation of PSD-95 is de-
creased at P0 in p35/ and p35/p39 double
knock-outmice,asdeterminedbyaphospho-
epitope-specific antibody that recognizes resi-
dues Thr-19 and Ser-25 (M. Morabito, M.
Sheng, and L.-H. Tsai, unpublished observa-
tions). To explore whether expression of p25
in p35/mice can restore phosphorylation
of PSD-95, we investigated the phosphoryla-
tion of PSD-95 in the compound mice com-
pared with p35-null animals. In the cortex of
p35/mice, phosphorylation is reduced by
30% compared with p35/ mice at P0
(Fig. 5B). Unlike in the case of mDab1, phos-
phorylation remains unaltered in the com-
pound mice, indicating a failure of p25/Cdk5
to phosphorylate PSD-95 in vivo during
development.
NUDEL, a lissencephaly 1-interacting
protein, displays diminished phosphory-
lation in mice with compromised Cdk5
function (Niethammer et al., 2000; Ko et al., 2001). One of the
phosphorylation sites targeted by Cdk5 is Ser-231 (Niethammer
et al., 2000). Indeed, phosphorylation of NUDEL at Ser-231 is
reduced by50% in the cortex of p35/mice compared with
control p35/ mice at E16 (Fig. 5C). Similar to the results
obtained by analysis of PSD-95 phosphorylation, we did not de-
tect a significant increase in Ser-231 phosphorylation of NUDEL
in p25-tg/p35/mice compared with p35/mice.
p25/Cdk5 phosphorylates tau protein at multiple sites in vitro
and in confined regions of the adult mouse brain that display high
levels of p25 (Ahlijanian et al., 2000; Lund et al., 2001). At P0,
however, tau phosphorylation at Ser-199, Ser-202, and Thr-205
(AT8 antibody) and Ser-396 and Ser-404 (PHF-1 antibody) does
not differ between wt and p35/p39 double knock-out mice brain
lysates (Ko et al., 2001). In support of this, we did not observe
changes in tau phosphorylation at the PHF-1 epitope between
p35/ control mice and p35 knock-out animals at P0 (Fig. 5D).
Additionally, we did not detect significant differences in tau
phosphorylation between p35/ and the compound animals.
The same results were obtained with an antibody that specifically
recognizes tau phosphorylation at Ser-202 (data not shown).
Similarly, Ahlijanian et al. (2000) did not observe changes in tau
phosphorylation at the AT8 and PHF-1 epitopes in adult mouse
brain lysates between wt and NSE p25-tg animals. It is possible
that hyperphosphorylation of tau in these animals only occurs in
restricted regions of the brain, or alternatively that p25/Cdk5
levels need to reach a certain threshold to achieve widespread
hyperphosphorylation of tau (see below).
In summary, we observe differences in the phosphorylation of
endogenous p35/Cdk5 substrates in the developing cortex of
p35/ mice compared with compound animals. On the one
hand, phosphorylation of mDab1 becomes partially restored in
p25-tg/p35/ mice; on the other, phosphorylation of the en-
dogenous substrates PSD-95 and NUDEL seems unaffected.
These results indicate that p25/Cdk5 can signal to pathways nor-
mally used by p35/Cdk5, but that some of the signaling of p35/
Cdk5 may be lost.
Pathogenic changes of the brain are detected in aged NSE
p25-tg mice
Four-month-old NSE p25-tg mice display a number of patho-
genic changes in certain brain regions, including hyperphospho-
rylation of neurofilament subunits and tau, increased number of
argyophilic neuronal somata, and disruption of the axonal cy-
toskeleton (Ahlijanian et al., 2000). Our p25-tg mice did not
show increased immunoreactivity for the phosphorylation-
dependent neurofilament antibody SMI 34 at 9 months of age or
appreciable differences after silver staining at 6 months of age
compared with wt animals (data not shown). This may suggest
that alteration of the genetic background from FVB/N (p25-tg
mice) to C57bl6 (p35/ mice) attenuates the phenotype of
p25-tg mice. Indeed, we observed degeneration of various brain
regions, including cerebral cortex and spinal cord, in 2-year-old
p25-tg and p25-tg/p35/ animals, whereas 6-month-old (data
not shown) and 9-month-old animals appeared histologically
normal (Fig. 6). FVB/N p25-tg mice display approximately a 1:1
ratio of p25 to endogenous p35 in 4-month-old cortices (Ahlija-
nian et al., 2000). To investigate whether the discrepancies in the
phenotype of FVB/N p25-tg mice to our mice might be a result of
differences in p25 levels, we tested for p25 levels in the cortices of
aged transgenic mice (Fig. 6D). The ratio of p25 to p35 is rela-
tively low in p25-tg/p35/ animals at P0. At 7 months of age,
the ratio is slightly increased, but in 28-month-old mice, p25
levels reach p35 levels. Therefore, low levels of p25 in our young
adult mice may account for the lack of pathogenic changes in
these animals compared with FVB/N p25-tg mice. In summary,
Figure 4. Expression of Cdk5 activators during development. Western blot analysis of lysates obtained from cerebral cortex at
different embryonic and postnatal stages (as indicated) is shown. A–D, p39 levels in littermates of each stage. Genotypes are
indicated. Throughout development, p39 levels are elevated in p35/ and p25-tg/p35/mice compared with p35/
control animals. p39 levels in p25-tg/p35/ mice are not increased compared with p35/ animals, indicating that the
partial rescue of the p35-null phenotype is not attributable to upregulation of p39 by p25. E, P25/35 levels in p25-tg/p35/
mice and p25 levels in p25-tg/p35/ mice. p35 levels strongly increase between E10.5 and E12.5 and continue to increase
throughout embryonic development. p25 levels are lower compared with p35 and reach higher levels only from E16 onward.
Similar results regarding p25 levels are obtained in p25-tg/p35/ and p25-tg/p35/mice.
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the absence of pathogenic changes in 6- and 9-month-old mice
that carry the p25 transgene indicates that the analysis of brain
morphology in the compound mice is not confounded by early
toxicity of p25. Deregulation of Cdk5 by moderate levels of p25,
however, does eventually result in remarkable pathogenic
changes in aged brains.
Discussion
To address the question of whether p25/Cdk5 signaling differs
from p35/Cdk5 signaling in vivo, we have generated NSE p25-tg
mice in a p35-null background. We find that expression of low
levels of p25 during development alleviates several aspects of the
p35/ phenotype independently of p39 levels. Consistent with
the phenotypic rescue, phosphorylation of the endogenous Cdk5
substrate mDab1 is partially restored in compound animals dur-
ing development. Our results provide evidence that p25/Cdk5
signals through pathways normally used by p35/Cdk5. Further-
more, analysis of the phosphorylation of other endogenous Cdk5
substrates in the compound mice indicates that p25/Cdk5 and
p35/Cdk5 signaling may differ to some extent in vivo.
Altered signaling of p25/Cdk5 compared with p35/Cdk5
Previous studies on p25/Cdk5-mediated signaling have indicated
that it differs from p35/Cdk5 signal transduction. Foremost,
p25-tg mice display breakdown of the axonal cytoskeleton, hy-
perphosphorylation of tau and neurofilament, as well as behav-
ioral abnormalities (Ahlijanian et al., 2000; Bian et al., 2002),
whereas p35-tg mice do not (Van den Haute et al., 2001). This
gain of toxic function might be explained by altered subcellular
localization of p25 compared with p35, which results in mislocal-
ization of active Cdk5 within the cell (Patrick et al., 1999;
Kusakawa et al., 2000; Lee et al., 2000). Furthermore, in vitro
studies on the phosphorylation of tau have indicated that p25/
Cdk5 could gain some toxic function by targeting phosphoryla-
tion sites within substrates that are less efficiently targeted by
p35/Cdk5 (Hashiguchi et al., 2002).
Although p25/Cdk5 appears to gain some toxic function, little
is known regarding further differences between p25/Cdk and
p35/Cdk5. More specifically, it is unknown whether p25/Cdk5
would phosphorylate the same substrates p35/Cdk normally tar-
gets. p25 has been shown to be a more stable protein than p35
(Patrick et al., 1998, 1999). Accordingly, accumulation of p25
could result in increased phosphorylation of endogenous p35/
Cdk5 substrates and might contribute to disturbed Cdk5 signal-
ing. Analysis of the signaling of p25/Cdk5 requires a system that
allows distinguishing unequivocally between p25/Cdk5 and p35/
Cdk5 and is therefore best performed in a system that lacks p35.
Our results from the p25-tg/p35/ mice indicate that p25/
Cdk5 can substitute for p35/Cdk5 at a cellular level in vivo. This is
best illustrated by the normal positioning of a subset of calbindin-
positive neurons as well as by the almost normal appearance of
4
in p35/ mice compared with p35/ animals, as determined by a phospho-epitope-
specific antibody targeting Ser-231. No significant changes are detected between p35/
mice and compound mice, indicating failure of p25/Cdk5 to phosphorylate NUDEL. D, Western
blot results obtained with anti-tau antibody PHF-1 to reveal phosphorylation at Ser-396 and
Ser-404 and with TAU-5 antibody to detect total tau protein. Quantification of lysates from P0
cortices shows that tau phosphorylation, unlike phosphorylation of mDab1, PSD-95, and NU-
DEL, appears unchanged between p35/ and p35/mice. No significant differences in
tau phosphorylation are detected between p35/ and compound mice. Statistical analysis
was performed by unpaired, two-tailed t test (n  3; *p  0.05; **p  0.01). Errors bars
indicate SEM. ko, p35/ animals; tgko, p25-tg/p35/ animals.
Figure 5. Phosphorylation of endogenous Cdk5 substrates during development. Western
blot analysis of lysates obtained from cerebral cortex of littermate mice is shown. A, E16 and P0
Western blot results using a phospo-epitope-specific antibody to Ser-491 of mDab1 and an
antibody recognizing total mDab1. Densitometric quantification of Western blot results reveals
that at both developmental stages, phosphorylation at Ser-491 relative to total mDab1 levels is
reduced by60% in p35/ compared with control p35/ animals (for which levels
were arbitrarily set to 1). However, phosphorylation is significantly increased in p25-tg/
p35/mice compared with p35-null mice. B, Western blot results using a phospo-epitope-
specific antibody to Thr-19 and Ser-25 of PSD-95 and an antibody recognizing total PSD-95.
Phosphorylation of PSD-95 is slightly decreased in p35/ compared with p35/ cortices
at P0. Quantification shows that phosphorylation levels are not significantly different between
p35/ and p25-tg/p35/mice. C, Western blot analysis of Ser-231 phosphorylation of
NUDEL and total NUDEL in the cerebral cortex of E16 mice. Phosphorylation is reduced by50%
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the hippocampus and the cerebellum in
the compound mouse. Therefore, in addi-
tion to a toxic gain of function by p25,
p25/Cdk5 must use signaling pathways in
the compound mice that are normally
used by p35 during development. Consis-
tent with this, we observed increased Ser-
491 phosphorylation of the endogenous
Cdk5 substrate mDab1 in the compound
mice compared with p35/ mice dur-
ing development. Interestingly, a study by
Hashiguchi et al. (2002) demonstrates
that p25/Cdk5 can phosphorylate all sites
of a substrate that are targeted by p35/
Cdk5, arguing that phosphorylation sites
overlap in vitro. Our results regarding
mDab1 phosphorylation now suggest that
p25/Cdk5 can target the same sites of a
substrate that are normally phosphory-
lated by p35/Cdk5 in vivo.
Despite these findings, our data indi-
cate that p25/Cdk5 cannot execute all
aspects of p35/Cdk5 signaling. First, p25/
Cdk5 fails to phosphorylate the endoge-
nous p35/Cdk5 substrates PSD-95 and
NUDEL during development, although it
is able to phosphorylate mDab1. Further-
more, we observed a slight increase of p39
levels in p35/mice throughout devel-
opment. p39 levels are similar in p25-tg/
p35/ animals compared with p35/
mice, which indicates that p25 cannot
compensate for the loss of p35 with regard
to regulation of p39 levels. Taken together, our in vivo results
implement new aspects of p25/Cdk5-mediated signaling com-
pared with p35/Cdk5, aside from a previously anticipated toxic
gain of function. On the one hand, p25/Cdk5 signals through
pathways that are normally used by p35/Cdk5; on the other, some
aspects of p35/Cdk5 signaling seem to remain lost in the presence
of p25/Cdk5.
Substrates of Cdk5 during development
Although several endogenous substrates of p35/Cdk5 have been
identified during nervous system development (Niethammer et
al., 2000; Keshvara et al., 2002), little is known regarding the
functions of these phosphorylation events. mDab1 is an essential
adaptor protein in the reelin pathway that regulates neuronal
positioning in the cerebral cortex (Rice and Curran, 2001). Phos-
phorylation of Ser-491 of mDab1 is strongly diminished in the
Cdk5/ brain (Keshvara et al., 2002). As such, two signaling
pathways that control cell positioning might cross talk via mDab1
(Keshvara et al., 2002). Our finding that increased Ser-491 phos-
phorylation of mDab1 in the compound mice correlates with a
partial rescue of the p35/ cell-positioning defect does not
contradict this hypothesis. Any further conclusions regarding the
function of Ser-491 phosphorylation of mDab1 remain specula-
tive. Unlike mDab1, NUDEL and PSD-95 did not show increased
phosphorylation in the compound mice compared with p35/
animals, suggesting that phosphorylation might not be necessary
for the phenotypic rescue. The residual phosphorylation of both
substrates in the p35/ cortex, however, seems higher than
that of mDab1. One possible explanation may be that the p39/
Cdk5 kinase has more impact on the phosphorylation of NUDEL
and PSD-95 than of mDab1. Given such uncertainties, we think
that conclusions with regard to the lack of phosphorylation and
the observed phenotype would be premature.
Reduced levels of p25 compared with p35
during development
Evaluation of p25/Cdk5 signaling during development ideally
requires expression of p25 in the same cells, at the same levels,
and at the same time as endogenous p35. Expression of p35 and
p39 is primarily neuronal (Lew et al., 1994; Tsai et al., 1994; Tang
et al., 1995), and analysis of Cdk5 chimeric mice has shown that
Cdk5 acts cell-autonomously in neurons (Ohshima et al., 1999).
Expression of transgenes from the NSE promoter is restricted to
differentiating and adult neurons (Forss-Petter et al., 1990). Con-
sistent with previously published results obtained from NSE
promoter-driven transgenes (Bernard et al., 1998), p25 can be
detected early in cortical development (E10.5), when expression
is comparable with endogenous p35 levels. During further em-
bryonic development, as expression levels of p35 increase, the
levels of p25 remain low relative to those of p35. Despite this
expression profile, some p25/Cdk5 signaling is induced during
development, resulting in alleviation of several aspects of the p35-
null brain phenotype in p25-tg/p35/ animals. The rescue is
not complete and results in an intermediate phenotype. Regard-
ing cell positioning, calbindin-positive neurons segregate into
two fractions, with one fraction being rescued and the other one
appearing unaffected. Given the relatively low expression levels of
the transgene compared with endogenous p35, some calbindin-
positive neurons might not attain sufficiently high expression of
p25 to allow migration to proper target areas. Alternatively, Cdk5
Figure 6. Aged p25-tg mice display brain degeneration. A, B, Coronal sections of paraformaldehyde-fixed mouse brains stained
with hematoxylin and eosin. The depicted area corresponds to deep layers of the lateral motorcortex at the level of the anterior
commissure. A, In 9-month-old mice, no obvious morphological degeneration is apparent in transgenic mice compared with
nontransgenic control mice (genotypes as indicated). B, In 2-year-old mice, a spongiform degeneration in the cortex is evident in
p25-tg and p25-tg/p35/mice compared with corresponding control animals. The spongiform degeneration is characterized
by large holes in the tissue, which often contain amorphous material. C, Cross sections of cervical spinal cord in 2-year-old animals.
The anterior horn of p25-tg mice displays a degeneration compared with wild-type animals. For all images, dorsal is at the top;
medial is to the left. Scale bars, 200m. D, p25 levels increase with age. Western blot analysis of p25 and p35 levels in the cerebral
cortex of p25-tg/p35/mice is shown. At P0, levels of p25 are relatively low compared with endogenous p35; however, they
increase slightly in 7-month-old (7mo) mice. In 28-month-old (28mo) animals, p25 levels are similar to p35 levels. The single lane
to the right is a longer exposure of the first P0 lane (compare with Fig. 4 E).
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signaling might differ within calbindin-positive neurons, render-
ing a subpopulation of them receptive to p25/Cdk5-mediated
signaling, whereas in another subpopulation, p25/Cdk5 cannot
substitute for p35/Cdk5. More instructive is the finding that
some calbindin-positive neurons resume normal positions
within the NSE p25-tg/p35/ cortex. This result is a proof of
principle that p25 can substitute for p35, at least in those neurons,
and it shows that p25/Cdk5 signaling must use pathways that
p35/Cdk5 is engaged in.
Layering in the cerebral cortex of p25-tg/p35/mice
A fraction of calbindin-positive pyramidal neurons in the motor-
cortex area resides in its normal position in layers II and III of the
compound mice. In contrast, SMI 32-positive large pyramidal
neurons are found superficial to their normal position. The mis-
localization of SMI 32-positive neurons in the cortex of the com-
pound mice might be explained in part by the inability of some
calbindin-positive neurons to reach superficial positions. This
would result in a thinning of layers II and III, which we indeed
find in the compound mice. Accordingly, if one assumes that the
position of SMI 32-positive neurons is rescued in the compound
mice, they should be found in slightly superficial locations com-
pared with wt mice, which is what we observe. In other words,
one could consider the position of SMI 32-positive neurons as
normal in relation to other layers of a wild-type-like but thinned
cortex, which resides superficial to a mass of neurons that failed
to reach normal positions. This view is supported by the presence
of a thin layer of small granule cells, which resemble layer IV
neurons, just above the layer of SMI 32-positive (layer V) neu-
rons in the compound mice (Fig. 1A). Taken together, p25/Cdk5
signaling seems to reestablish accurate positioning of presump-
tive layer V, some layer IV, and a fraction of layer II and III
neurons. Hence, expression of p25 appears to be sufficient to
substitute for p35 in a subset of neurons destined for layers II–V,
which are the layers primarily affected in Cdk5-deficient mice
(Gilmore and Herrup, 2001).
On the basis of our findings, we hypothesize an altered and
adverse signaling of Cdk5 under conditions that generate p25.
First, p25/Cdk5 gains some toxic function. Second, a buildup of
p35/p25 over the normal levels of endogenous p35 could result in
hyperphosphorylation of some substrates of p35/Cdk5. Third,
p25/Cdk5 could be unable to perform all aspects of normal p35/
Cdk5 signaling. Taken together, our findings provide a basis on
which changes in Cdk5 signaling under pathological conditions
that generate p25 can be investigated further.
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